Ergoteles’s MiMedx Group MDXG Stock Holding History

Ergoteles’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,300	Closed	-$332K	–	523
2023 Q2	$332K	Buy	+50,300	New	+$256K	0.02%	741

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ergoteles's MDXG Position: Q3 2023 in Review

Ergoteles sold out of MiMedx Group (MDXG) in Q3 2023, closing a stake of 50,300 shares — an estimated $332K sold.

Ergoteles first reported a position in MDXG in Q2 2023 and held it in 1 quarter. The position peaked at $332K in Q2 2023. 185 funds tracked by Wall St. Rank hold MDXG as of Q3 2023.

Ergoteles reported no remaining MiMedx Group position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 50,300 MiMedx Group shares in Q3 2023, an estimated $332K.
Ergoteles first reported a position in MiMedx Group in Q2 2023 and held it in 1 quarter.
Ergoteles's MiMedx Group position peaked at $332K in Q2 2023.
185 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.